NM_020661.4(AICDA):c.48A>G (p.Lys16=) AND Hyper-IgM syndrome type 2
- Germline classification:
- Conflicting interpretations of pathogenicity (2 submissions)
- Last evaluated:
- Jan 18, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001085627.14
Allele description [Variation Report for NM_020661.4(AICDA):c.48A>G (p.Lys16=)]
NM_020661.4(AICDA):c.48A>G (p.Lys16=)
Condition(s)
Assertion and evidence details
Last Updated: Apr 15, 2024